Mangalam Drugs & Organics Limited (NSE:MANGALAM)

India flag India · Delayed Price · Currency is INR
30.50
+0.95 (3.21%)
Apr 6, 2026, 3:28 PM IST
Market Cap461.55M -63.9%
Revenue (ttm)2.38B -31.5%
Net Income-309.21M
EPS-19.53
Shares Outn/a
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume35,865
Average Volume48,892
Open30.39
Previous Close29.55
Day's Range28.56 - 30.80
52-Week Range22.80 - 95.00
Beta0.07
RSI45.67
Earnings DateMay 30, 2026

About Mangalam Drugs & Organics

Mangalam Drugs & Organics Limited, together with its subsidiary, manufactures and sells active pharmaceutical ingredients (APIs) and intermediates in India. The company offers active pharmaceutical ingredients (API) products, including acyclovir, amodiaquine, artemether, artesunate, bisoprolol fumarate, chloroquine phosphate, dihydroartemisinin, dolutegravir sodium, efavirenz, emtricitabine, etodolac, furosemide, hydroxychloroquine sulphate, lumefantrine, nimesulide, nitrofurantoin anhydrous and monohydrate, olanzapine, primaquine and piperaqui... [Read more]

Sector Healthcare
Founded 1972
Employees 480
Stock Exchange National Stock Exchange of India
Ticker Symbol MANGALAM
Full Company Profile

Financial Performance

Financial Statements